Prevention With Healsea in Adults Against Respiratory Infection Study

NACompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

November 29, 2024

Primary Completion Date

April 28, 2025

Study Completion Date

April 28, 2025

Conditions
Healthy Subjects (HS)
Interventions
DEVICE

Healsea Children nasal spray

dosage: 1 puff in each nostril twice daily during 3 treatment periods of 28 days interspersed by 2 wash-out periods of 10 days

Trial Locations (1)

1680

Diagnostics and Consultation Center Convex EOOD,, Sofia

Sponsors
All Listed Sponsors
lead

Lallemand Pharma AG

INDUSTRY

NCT06613906 - Prevention With Healsea in Adults Against Respiratory Infection Study | Biotech Hunter | Biotech Hunter